Project Grant R01HL182952
- Federal Project Grant Award Summary The University of California, San Diego received a $609,574 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026, through March 31, 2030. This award funds basic research investigating the cellular and molecular mechanisms that regulate cardiac chamber morphology, specifically focusing on how cardiomyocytes acquire distinct shapes and organizational...
- Federal Grant Award Summary The University of California, San Diego received a $3,008,247 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for August 31, 2029. This research grant supports investigation of cell-type specific mechanisms underlying mitral valve prolapse (MVP), one of the most prevalent valvular heart diseases affecting 2-3% of the general...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $1,113,961 to The Regents of the University of California, San Francisco on August 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support basic research investigating the mechanisms by which centrioles control mammalian development. The four-year project, concluding May 31, 2029, focuses on understanding how centriole defects contribute to human congenital disorders...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant of $1,072,936 to the University of California, San Diego, effective September 15, 2025, through June 30, 2029, under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports fundamental research investigating protein aggregation mechanisms in hematopoietic stem cells (HSCs), with the primary deliverable being scientific research and discovery designed to advance...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant of $799,256 to the University of California, San Diego on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The research project, "Cardiac Protection by Neuromodulation After Myocardial Infarction," extends through March 31, 2031, and investigates the mechanisms by which neuromodulation can mitigate adverse cardiac remodeling following...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $231,552 Project Grant to the University of California, San Diego on September 16, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This research project, titled "Tissue Elasticity and Viscosity Modulates Macrophage-Fibroblast Signaling in Cardiac Fibrosis," focuses on investigating the mechanisms underlying cardiac fibrosis through the study of interactions between...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Regents of the University of California, San Francisco a $778,504 Project Grant effective July 1, 2026, through February 28, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports mechanistic research investigating the molecular mechanisms controlling lung capillary specialization, plasticity, and function during early postnatal development. The research...
- Federal Project Grant Award Summary The University of California, San Diego received a $216,714 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 15, 2025, with a completion date of May 31, 2027. This award supports research and development of a novel ultrashort echo-time (UTE) magnetic resonance imaging (MRI) technique, specifically delta-TE-UTE MRI, designed to accurately map T2* values in...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,559,572 Project Grant to the Regents of the University of California, San Francisco on June 17, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports fundamental research into the multiciliation cycle, a specialized cell cycle variant that coordinates the biogenesis of hundreds of centrioles and cilia in multiciliated cells. The project investigates how...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $173,259 to the University of California, San Diego, with a performance period from September 1, 2025, through August 31, 2028, under the Cardiovascular Diseases Research program (CFDA 93.837). This grant supports fundamental research investigating the role of Kruppel-like factor-6 (KLF6) in lung development. The principal investigator will conduct research to delineate KLF6's...
Federal Project Grant Award Summary The University of California, San Diego received a $779,600 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with an award date of July 10, 2026 and expected completion by April 30, 2030. This award funds research to elucidate the mechanisms of left ventricle development and morphogenesis through comprehensive investigation of how diverse cardiac cell types emerge from developmental heart fields and coordinate to form complex cardiac structures. The research employs single-cell transcriptomic analyses, computational trajectory modeling, and lineage tracing techniques using genetically modified mouse models to define the gene regulatory networks that direct cardiac cell differentiation and regional specification within the left ventricle. The project investigates the hypothesis that the left ventricle develops from at least two distinct developmental sources—rather than a single field as previously reported—which create specific anteroseptal and posterolateral regions. The research deliverables include identification and characterization of developmental heart field progenitors, molecular mapping of gene regulatory networks controlling left ventricle cardiomyocyte specification, and spatiotemporal analysis of how distinct progenitor populations contribute to left ventricle morphogenesis. These outcomes advance fundamental understanding of cardiac development and may inform approaches to congenital heart disease and regenerative cardiac medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $779.6k | 7/9/26 |